ARH-049020

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C24H31NO6
Molecular Weight	429.506
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCO[C@@H](CC1=CC=C(OCCC2=CC=C(NC(=O)OC(C)(C)C)C=C2)C=C1)C(O)=O

InChI

InChIKey=QNDFBOXBUCDYNZ-NRFANRHFSA-N

InChI=1S/C24H31NO6/c1-5-29-21(22(26)27)16-18-8-12-20(13-9-18)30-15-14-17-6-10-19(11-7-17)25-23(28)31-24(2,3)4/h6-13,21H,5,14-16H2,1-4H3,(H,25,28)(H,26,27)/t21-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C24H31NO6
Molecular Weight	429.506
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 11:47:15 GMT 2023` Edited by `admin` on `Sat Dec 16 11:47:15 GMT 2023`
Record UNII	M8KS4A7P9P
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ARH-049020

Code

English

AR-H049020

Code

English

BENZENEPROPANOIC ACID, 4-(2-(4-(((1,1-DIMETHYLETHOXY)CARBONYL)AMINO)PHENYL)ETHOXY)-.ALPHA.-ETHOXY-, (.ALPHA.S)-

Systematic Name

English

(2S)-3-(4-(2-(4-(TERT-BUTOXYCARBONYLAMINO)PHENYL)ETHOXY)PHENYL)-2-ETHOXY-PROPANOIC ACID

Systematic Name

English

AR-H 049020XX

Code

English

(S)-3-(4-(4-((TERT-BUTOXYCARBONYL)AMINO)PHENETHOXY)PHENYL)-2-ETHOXYPROPANOIC ACID

Systematic Name

English

X-334

Code

English

X334

Code

English

Code System Code Type Description

CAS

251454-45-2

Created by admin on Sat Dec 16 11:47:15 GMT 2023 , Edited by admin on Sat Dec 16 11:47:15 GMT 2023

PRIMARY

FDA UNII

M8KS4A7P9P

Created by admin on Sat Dec 16 11:47:15 GMT 2023 , Edited by admin on Sat Dec 16 11:47:15 GMT 2023

PRIMARY

PUBCHEM

9910505

Created by admin on Sat Dec 16 11:47:15 GMT 2023 , Edited by admin on Sat Dec 16 11:47:15 GMT 2023

PRIMARY

Related Record Type Details


					M8KS4A7P9P

ARH-049020

ACTIVE MOIETY

Comments:

AstraZeneca also has two apparent glitazones in their R&D pipeline, code named AZ 242 and AR-H049020. Neither Merck nor AstraZeneca, however, were available to comment on the issue of liver toxicity with respect to their agents.